| Title | Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. | | Author(s) | Douzinas EE, Flevari K, Andrianakis I, Betrosian AP | | Institution | 3rd Department of Critical Care, Athens University, Evgenidion Hospital, Athens, Greece. | | Source | Scand J Infect Dis 2009 Nov 2. | | Abstract | Abstract We present a case of severe Pneumocystis jirovecii pneumonia and coexisting cytomegalovirus infection in a glucose-6-phosphate dehydrogenase (G6PD) enzyme deficient woman with anaplastic astrocytoma on temozolomide and corticosteroid therapy. She was successfully treated with oral atovaquone and ganciclovir. Atovaquone represents a safe alternative in severe Pneumocystis infection when trimethoprim-sulfamethoxazole (co-trimoxazole) is contraindicated. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19883154 |
|
